CF CAN TRANSCATHETER HEART VALVE REPAIR, REPLACEMENT AND ASSOCIATED DEVICES
Who
| Buyer | Supply Chain Coordination Limited — not a council we hold |
| Supplier | ABBOTT MEDICAL U.K. LIMITED |
| Supplier | Acrostak-UK Ltd |
| Supplier | BIOSENSORS INTERNATIONAL UK LIMITED |
| Supplier | BOSTON SCIENTIFIC LTD |
| Supplier | BVM MEDICAL LTD |
| Supplier | Dot Medical Limited |
| Supplier | Edwards Lifesciences |
| Supplier | JenaValve Production Ltd. |
| Supplier | MCT Lifesciences Ltd |
| Supplier | MEDTRONIC LTD |
| Supplier | Meril UK Pvt Ltd |
| Supplier | SAHAJANAND MEDICAL TECHNOLOGIES (SMT) UK |
What
NHS Supply Chain seeks to establish a non-exclusive framework agreement for the supply of percutaneous valve repair and replacement devices to NHS Supply Chain customers via the non-direct route of supply. Certain products within this framework agreement are classified as high cost tariff excluded devices under the NHS England Specialised Services Devices Programme (SSDP) (formerly known as the High-Cost Tariff-Excluded Devices programme) . Trusts who are commissioned to provide specialised services in England are directed to purchase all their SSDP requirements through a national supply route via NHS Supply Chain. It is anticipated that initial expenditure will be in the region of £130,000,000 to £160,000,000 in the first year of this framework agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value over the total framework agreement term is £880,000,000
Dates and source
| Runs | 18 Sep 2023 to 17 Sep 2027 |
| OCID | ocds-b5fd17-37a87f9c-4070-4a61-a4fe-1977933d840d |
| Notice | Read it on Contracts Finder |
Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.